{
  "id": 19420805,
  "title": "Bionano Genomics earnings missed by $0.03, revenue fell short of estimates",
  "url": "https://urgent.news/2026/11/11/bionano-genomics-earnings-missed-by-0-03-revenue-fell-short-of",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-11T00:32:18.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/earnings/bionano-genomics-earnings-missed-by-003-revenue-fell-short-of-estimates-5017406"
  },
  "original_language": "en",
  "account": "Bionano Genomics (NASDAQ: BNGO) released its third quarter results, revealing that earnings per share (EPS) fell short of expectations. The company reported an EPS of $-0.4500, $0.03 below the analyst consensus of $-0.4200. Additionally, revenue for the quarter was $8.28M, significantly lower than the estimated $8.75M. Looking ahead, Bionano Genomics predicts FY 2026 revenue to be between $31.0000M and $33.0000M, which is below the analyst consensus of $32.4700M. The stock price of Bionano Genomics closed at $1.23, marking a 4.2400% increase over the last three months but a 23.1300% decline over the past 12 months. The company has experienced 1 positive and 0 negative EPS revisions in the past 90 days. Bionano Genomics is currently assessed as having a fair performance financial health score. To view the stock's historical reactions to earnings and explore the company's financials, visit Investing.com's dedicated resource. For a comprehensive list of upcoming earnings reports, refer to Investing.com's earnings calendar.",
  "summary": null,
  "key_points": [
    "Bionano Genomics EPS missed by $0.03, at -$0.4500",
    "Revenue fell short of estimates at $8.28M vs $8.75M",
    "FY 2026 revenue forecast below analyst consensus at $31M-$33M"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}